Meeting Report

2nd MENA Stakeholder Meeting on Biosimilars 2018 – Report

Published in: Volume 8 / Year 2019 / Issue 2
Author(s): , ,
Page: 76-87

Author byline as per print journal: Andrea Laslop, MD; Jian Wang, MD, PhD; Robin Thorpe, PhD, FRCPath Introduction: The number of biosimilars, or similar biotherapeutic products, is expanding rapidly worldwide.… Read More »

First GCC stakeholder meeting on approval process, interchangeability/substitution and safety of biosimilars 2017 – Report

Published in: Volume 7 / Year 2018 / Issue 4
Author(s): , , , , , , ,
Page: 158-63

Author byline as per print journal: Gianluca Trifirò, MD, PhD; Meteb Al-Foheidi, MD, FRCPC; Ali M Alhomaidan, PhD; Ahmed H Aljedai, PharmD, MBA, BCPS, FCCP, FAST; Musaed Abdullah Alkholief, PhD;… Read More »

First ASEAN educational workshop on regulation and approval of biosimilars/similar biotherapeutic products 2017 – Report

Published in: Volume 7 / Year 2018 / Issue 3
Author(s): , ,
Page: 127-32

Author byline as per print journal: Robin Thorpe, PhD, FRCPath; Elwyn Griffiths, PhD, DSc; Niklas Ekman, PhD Abstract: Biosimilar medicines are being increasingly developed and used worldwide. Many regulatory agencies across… Read More »

Quality assessment of biosimilars in Colombia – reducing knowledge gaps

Published in: Volume 7 / Year 2018 / Issue 2
Author(s): , ,
Page: 79-83

Abstract: Biosimilar medicines are having a global effect, and as such regulatory agencies worldwide are assessing how to respond to them. Here, two events held by GaBI for the Colombian… Read More »

Perspectives on the future of pegfilgrastim biosimilars

Published in: Volume 6 / Year 2017 / Issue 4
Author(s): , ,
Page: 185-7

Author byline as per print journal: Professor Pere Gascón, MD; Ruediger Jankowsky, PhD; Karsten Roth, PhD Abstract: Cinfa Biotech, the biosimilars specialists of the Cinfa Group, reviewed pegfilgrastim biosimilar approaches to… Read More »

Value-added medicines: how repurposed medicines bring value to patients and pharmacists

Published in: Volume 6 / Year 2017 / Issue 3
Author(s): , ,
Page: 141-6

Author byline as per print journal: Christoph Stoller; Professor Stephan Krähenbühl, MD, PhD; Emilia Minodora Voiculescu, PharmD Abstract: The Value Added Medicines Group of Medicines for Europe met at the 2017 European… Read More »

Pharmacovigilance, traceability and building trust in biosimilar medicines

Published in: Volume 6 / Year 2017 / Issue 3
Author(s): , ,
Page: 135-40

Author byline as per print journal: Professor Teun van Gelder, MD, PhD; Benedicte Lunddahl, DVM; Professor Barbara OM Claus, PharmD, PhD Abstract: The Medicines for Europe’s Biosimilar Medicines Group met at the… Read More »

Roundtable on registries: practical considerations for registries – making them work, London, UK, 26 January 2017

Published in: Volume 6 / Year 2017 / Issue 3
Author(s): , , , , , ,
Page: 122-34

Author byline as per print journal: Stuart Bloom, DM, FRCP; Keith Bodger, MBChB(Honours), MD, FRCP; Fraser Cummings, BMSc(Hons), MBChB, MRCP(UK), DPhil, FRCP; Professor Sarah Garner, BPharm, PhD; Professor Kimme Hyrich, MD, PhD, FRCPC; Clare… Read More »

Biosimilar product labels in Europe: what information should they contain?

Published in: Volume 6 / Year 2017 / Issue 1
Author(s):
Page: 38-40

Abstract: In 2016, a multi-stakeholder workshop was held on the topic of ‘Biosimilar Labelling’. The discussions concerning labelling particulars are outlined in this meeting report. Submitted: 21 November 2016; Revised:… Read More »

Roundtable on biosimilars: pharmacovigilance, traceability, immunogenicity, 15 November 2016, Madrid, Spain

Published in: Volume 6 / Year 2017 / Issue 1
Author(s): , , , , , , , ,
Page: 31-7

Author byline as per print journal: Professor Francisco José de Abajo, MD, MPH, PhD; Professor Joan Albanell, MD; Olga Delgado Sanchez, PharmD; Kevin Klein, MSc; José Vicente Moreno-Muelas, MD; Sol Ruiz, PhD; Professor… Read More »

Page 1 of 3 1 2 3 Next »
Go Back Print